Establish standardised costing and outcome assessment measures for optimised national healthcare provision in the European Union

Maastricht University

Maastricht University logo

Maastricht University (UM) is the most international university in the Netherlands, and stands out for its innovative approach to learning and international outlook. With almost 16,000 students and 4,000 staff members, UM offers a wide choice of academic programmes, among others in the field of participation and health economics. Within the UM, the Care and Public Health Research Institute (CAPHRI) provides high quality multidisciplinary research and teaching aimed at the improvement of the individual's quality of life, participation and the population's health through (cost-effective) innovation in public health and health care.

Main tasks in the project

Main tasks in the project include 1) lead on WP2 (criminal justice and educational sectors), 2) co-lead on HA3 (measurement) and 3) provision of country-specific contributions for the Netherlands in collaboration with EUR.

Expertise of staff members involved

  • Prof. Silvia Evers

    Prof. Silvia Evers, Professor of Public Health Technology Assessment at Maastricht University, Netherlands, in the Department of Health Services Research of the Faculty of Health, Medicine and Life Science. Next to that, she is working at the Trimbos Institute, Netherlands, Institute of Mental Health and Addiction, Centre of Economic Evaluation. At Maastricht University, Prof Evers is leader of the programme ‘Creating value-based health care’ and profile coordinator of the HTA-trace of the Health Sciences Research Master at CAPHRI, Research School of Public Health and Primary Care. Currently, she has been the co-supervisor of more than 20 PhD students and more than 100 Bachelor and Master Students. She has co-authored up to 200 (peer-reviewed) publications (Google’s H-index 34). Her chief current research efforts are directed towards the methodology of economic evaluation of (preventive) interventions, meta-analysis, transferability and quality of life analysis.

  • Prof. Carmen Dirksen

    Prof. Carmen Dirksen, professor in Health Technology Assessment (HTA) of clinical interventions at the Care and Public Health Research Institute (CAPHRI), Maastricht University, and head of the department Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht UMC+. She chairs the Dutch Society for Technology Assessment in Health Care (NVTAG). She has over 20 years of experience in HTA, and has been involved in many economic evaluation studies covering various disciplines, among them (youth) mental health. She has supervised 14 PhD students in the past, and is currently supervisor of 12 PhD students. Additionally, she (co-)authored over 140 peer reviewed journal articles.

  • Dr Aggie T.G. Paulus

    Dr Aggie T.G. Paulus, Associate Professor in Health Economics, Chair of Program Committee Health, Program Director Master Healthcare Policy, Innovation and Management (Maastricht University – Faculty of Health, Medicine and Life Sciences). Since 1990, Dr Paulus has gained ample experience in conducting research and acting as a co-promotor and/or supervisor of PhD students, researchers and postdocs. She has an interest and has been involved in various multidisciplinary researches, combining health economics with other disciplines, including policy and organisational sciences. She (co-)authored over 170 publications, including scientific articles, reports, book chapters and books. Her academic focus is particularly on inter-sectoral costs and benefits of interventions in health care, the broader economic impacts of interventions and policy measures in health care, intra-organisational care arrangements, health care reform and innovations in health care.

  • Luca M. M. Janssen

    Luca M. M. Janssen, PhD – candidate, obtained a BSc in Prevention and Health at Maastricht University, and is currently finishing her MSc Research Master in Health Sciences with specialization Health Technology Assessment. For her master thesis she conducted a burden of disease study investigating the economic impact of type 2 diabetes.

  • Dr Ruben Drost

    Dr Ruben M.W.A. Drost, Assistant Professor at Maastricht University, Department of Health Services Research of the Faculty of Health, Medicine and Life Sciences. In 2016, he successfully defended his PhD thesis on the societal perspective within health economic evaluations and the identification, classification and valuation of costs and benefits outside the healthcare sector, also known as ‘intersectoral costs and benefits’. In his career up until now, he (co-)authored over 10 publications, including scientific articles and reports. His current academic focus is particularly on the societal perspective and societal cost benefit analysis, which he combines with teaching activities, such as giving lectures, tutoring and supervising both Bachelor’s and Master’s students.